腺样体肥大伴常年性鼻炎患儿的致敏原谱及临床特点分析

王子熹, 林枫, 李丽莎, 等. 腺样体肥大伴常年性鼻炎患儿的致敏原谱及临床特点分析[J]. 临床耳鼻咽喉头颈外科杂志, 2019, 33(4): 351-353. doi: 10.13201/j.issn.1001-1781.2019.04.015
引用本文: 王子熹, 林枫, 李丽莎, 等. 腺样体肥大伴常年性鼻炎患儿的致敏原谱及临床特点分析[J]. 临床耳鼻咽喉头颈外科杂志, 2019, 33(4): 351-353. doi: 10.13201/j.issn.1001-1781.2019.04.015
WANG Zixi, LIN Feng, LI Lisha, et al. Analysis of sensitization spectrum and clinical features of children with adenoid hypertrophy and perennial rhinitis[J]. J Clin Otorhinolaryngol Head Neck Surg, 2019, 33(4): 351-353. doi: 10.13201/j.issn.1001-1781.2019.04.015
Citation: WANG Zixi, LIN Feng, LI Lisha, et al. Analysis of sensitization spectrum and clinical features of children with adenoid hypertrophy and perennial rhinitis[J]. J Clin Otorhinolaryngol Head Neck Surg, 2019, 33(4): 351-353. doi: 10.13201/j.issn.1001-1781.2019.04.015

腺样体肥大伴常年性鼻炎患儿的致敏原谱及临床特点分析

详细信息
    通讯作者: 关凯,E-mail:dr_guankai@126.com
  • 中图分类号: R765.21

Analysis of sensitization spectrum and clinical features of children with adenoid hypertrophy and perennial rhinitis

More Information
  • 目的:探讨腺样体肥大伴常年性鼻炎患儿的致敏原谱及临床特点。方法:纳入2017-07-2017-10期间在首都儿科研究所附属儿童医院耳鼻咽喉科门诊及北京协和医院变态反应科门诊就诊的121例腺样体肥大伴常年性鼻炎患儿,采集病史进行鼻咽镜检查,检测特异性IgE,对患儿的致敏原谱及临床特点进行分析。结果:腺样体肥大伴变应性鼻炎(AR)患儿占64.5%,真菌致敏最常见,占AR患儿的78.2%,其中男童占67.2%,性别差异有统计学意义(P<0.05)。伴AR的患儿镜下表现相对更严重,划分为4度者的比例更高,占镜下4度患儿总例数的75.0%,而无明确致敏原的患儿只占25.0%,二者差异有统计学意义(P<0.05)。结论:AR与腺样体肥大关系密切,应重视变应原对腺样体肥大患儿临床表现的影响。
  • 加载中
  • [1]

    JEFFERSON Y.Mouth breathing:adverse effects on facial growth,health,academics,and behavior[J].Gen Dent,2010,58:18-25.

    [2]

    王子熹,林枫,庞冲,等.腺样体肥大伴变应性鼻炎的临床表现与治疗[J].中国中西医结合耳鼻咽喉科杂志,2018,26(3):238-240.

    [3]

    PAPAIOANNOU G,KAMBAS I,TSAOUSSOGLOU M,et al.Age-dependent changes in the size of adenotonsillar tissue in childhood:implications for sleep-disordered breathing[J].J Pediatr,2013,162:269-274.

    [4]

    KOYCU A,AYDIN E,TULGAR KINIK S.Changes in body composition and growth pattern after adenotonsillectomy in prepubertal children[J].Int J Pediatr Otorhinolaryngol,2016,81:46-50.

    [5]

    SCADDING G.Non-surgical treatment of adenoidal hypertrophy:the role of treating IgE-mediated inflammation[J].Pediatr Allergy Immunol,2010,21:1095-1106.

    [6]

    EVCIMIK M F,DOGRU M,CIRIK A A,et al.Adenoid hypertrophy in children with allergic disease and influential factors[J].Int J Pediatr Otorhinolaryngol,2015,79:694-697.

    [7]

    WARMAN M,GRANOT E,HALPERIN D.Improvement in allergic and nonallergic rhinitis:A secondary benefit of adenoidectomy in children[J].Ear Nose Throat J,2015,94:4-7.

    [8]

    BHARGAVA R,CHAKRAVARTI A.A double-blind randomized placebo-controlled trial of topical intranasal mometasone furoate nasal spray in children of adenoidal hypertrophy with otitis media with effusion[J].Am J Otolaryngol,2014,35:766-770.

    [9]

    SAKARYA E U,BAYAR MULUK N,SAKALAR E G,et al.Use of intranasal corticosteroids in adenotonsillar hypertrophy[J].J Laryngol Otol,2017,131:384-390.

    [10]

    CHOHAN A,LAL A,CHOHAN K.Systematic review and meta-analysis of randomized controlled trials on the role of mometasone in adenoid hypertrophy in children[J].Int J Pediatr Otorhinolaryngol,2015,79:1599-1608.

    [11]

    刘炜,陈仁杰.糠酸莫米松鼻喷剂联合孟鲁司特钠治疗儿童腺样体肥大的疗效观察[J].临床耳鼻咽喉头颈外科杂志,2017,31(5):366-368.

  • 加载中
计量
  • 文章访问数:  314
  • PDF下载数:  925
  • 施引文献:  0
出版历程
收稿日期:  2018-12-08

目录